Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen
- Status
- COMPLETED
- Phase
- PHASE3
GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
- Status
- COMPLETED
- Phase
- PHASE2
Bone Health in Aging HIV Infected Women
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1
Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)
- Status
- COMPLETED
- Phase
- PHASE2
Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs
- Status
- COMPLETED
- Phase
- NA
Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of HepCure Toolkit to Improve Harvoni Adherence
- Status
- COMPLETED
- Phase
- NA
Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820
- Status
- TERMINATED
- Phase
- PHASE4
Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
- Status
- COMPLETED
- Phase
- PHASE4
Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection
- Status
- COMPLETED
- Phase
- PHASE3
Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3